Privia Health
Runs billing, tech, and back office for independent physician practices nationwide.
The call
Privia keeps adding doctors and revenue fast, but its stock price assumes nothing goes wrong while Medicare Advantage and taxes both tighten.
Privia Health is a company that helps smaller medical practices run their businesses and negotiate with insurance companies so they can stay independent instead of being bought by huge hospital systems like Optum. It's hard to copy because doctors are locked in by contracts, state rules, and software they use every day, and 98 percent stay with Privia year after year. A direct competitor called Aledade does something similar, so Privia has to keep proving it serves doctors better. The big risk is that the stock price assumes everything goes perfectly, yet when Privia beats revenue targets but misses profit targets (like in early 2026), investors sell the stock anyway, suggesting the market is betting Privia cannot keep its momentum and may struggle as it becomes more dependent on patient payments instead of investor money in 2026.
Why
01
AI pressure: AI scribe and coding tools like Abridge and Ambience Healthcare. If practices adopt AI scribing and coding directly, Privia's bundled admin fees get squeezed out. Could AI do the core job? Unlikely.
02
Bigger players: Optum (UnitedHealth Group). Optum keeps buying primary care groups outright, competing for the same doctors Privia signs as partners. Could a giant copy it? No, they are blocked.
03
What protects it. State licensure, payer contracts, and single tax ID group structure lock doctors into Privia's system once they join.
What would change this call
Provider count growth rate in Q2/Q3 2026 filings versus prior +12.3% YoY pace. Slowing adds could show Aledade or others winning practices in Privia states.
Gross provider retention figure in next 10-Q, still near 98%. A drop would show practices leaving for rivals or reverting to legacy structures.
MA-related attributed lives trend after management's 'challenging' MA comments. Continued MA losses would show payer-side pressure cracking Privia's model.
Gross provider retention figure in next 10-Q, still near 98%. A drop would show practices leaving for rivals or reverting to legacy structures.
MA-related attributed lives trend after management's 'challenging' MA comments. Continued MA losses would show payer-side pressure cracking Privia's model.
Key numbers
- $2.25B trailing revenue, up 26% YoY
- 98% provider retention over three years
- Stock trades near 125x FY26 EPS estimate
Named risks
- High stock valuation (P/E ~125) leaves little room for execution missteps like Q1 2026 EPS miss.
- Transition to full cash-taxpayer status in 2026 expected to compress free cash flow conversion.
- Medicare Advantage market described by management as challenging in 2026 guidance.
- Data breach affecting 74,456 individuals disclosed November 17, 2025 exposes company to litigation.
- Insider selling by former CEO and current CEO in mid-2026 (~$6.3M combined) could signal caution.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Aledade | contesting | Direct peer in independent-practice/ACO enablement, industry analysis notes strong performance as of 2024-03-14 |
| Optum (UnitedHealth Group) | contesting | Far larger incumbent with 90,000+ clinicians, but employed-physician model conflicts with Privia's independence pitch |
| agilon health | gaining on | Reported medical-margin volatility in its Medicare Advantage risk book as of 2026-03-20 analysis |
| Evolent Health | gaining on | Sold its ACO/MSSP business to Privia for $100M, closed December 5, 2025, reducing direct overlap |
| Hippocratic AI | contesting | AI-native entrant raised $126M Series C at $3.5B valuation, November 2025, targeting adjacent patient-engagement workflows |
Questions people ask
- Is Privia Health profitable in 2026?
- Privia Health reported Adjusted EBITDA of $125.5M for FY2025 (up 38.8% YoY) and guided FY2026 Adjusted EBITDA of $145-155M, but Q1 2026 GAAP EPS was just $0.02, missing estimates by about 73%, as reported May 7, 2026.
- Could AI replace Privia Health's business model?
- AI tools like Navina (partnered since September 2023) enhance physician workflows and data insights, but Privia's core value is regulatory licensure, payer contracts, single-TIN medical-group structure, and a 98% three-year provider retention rate that AI alone cannot replicate.
- Who owns Privia Health?
- Privia Health Group is a public company on Nasdaq under ticker PRVA since its April 29, 2021 IPO at $23/share. Founding sponsor Welsh, Carson, Anderson & Stowe reduced its stake via secondary offerings through 2024, with institutional holders like Vanguard and BlackRock dominant by 2025.
- Who is Privia Health's biggest competitor?
- Aledade is Privia Health's closest direct peer in independent-practice/ACO enablement, per industry analysis dated 2024-03-14. Optum (UnitedHealth Group) is the larger incumbent threat, though its employed-physician model structurally differs from Privia's independence-preserving pitch.
- Did Privia Health have a data breach?
- Yes. Privia Medical Group West Texas PLLC disclosed a cybersecurity incident to the Texas Attorney General on November 17, 2025, initially reported as affecting about 2,024 individuals but later updated to 74,456, exposing personal, health, financial, and Social Security data.
- What is Privia Health's revenue in 2025-2026?
- Privia Health's trailing-twelve-month revenue reached about $2.25B as of February 27, 2026. Q1 2026 revenue was $603.85M, up 25.8% YoY. FY2026 guidance calls for revenue of $3.65-3.75B, per company reporting dated May 7, 2026.
Timeline
- 2026-07-12Former CEO Shawn Morris and CEO Parth Mehrotra disclosed insider stock sales totaling about $6.3M
- 2026-05-07Q1 2026 results: revenue $603.85M (+25.8% YoY) beat estimates, EPS $0.02 missed forecasts
- 2026-05-01Privia Health announced expansion into New Jersey
- 2026-02-27FY2025 results: ~$2.25B TTM revenue, $125.5M Adjusted EBITDA (+38.8% YoY), 5,380 providers
- 2025-12-05Closed acquisition of Evolent Health's ACO business for $100M cash plus up to $13M contingent
- 2025-11-17Data breach disclosed to Texas AG, later updated to affect 74,456 individuals
- 2025-09-23Signed definitive agreement to acquire Evolent's ACO/value-based primary care unit
- 2023-09-14Announced AI partnership with Navina for point-of-care physician insights
- 2023-01-01Parth Mehrotra promoted to CEO
- 2021-04-29IPO on Nasdaq at $23/share, raising approximately $448.5M
Revision history
22 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Privia Health Group Q4 Earnings Call Highlights (2026-02-27)
- Taking a Look at Key Metrics Versus Estimates (2026-05-07)
- Privia Health Group (PRVA) Investor Relations, Earnings Summary & Outlook (2026-07-07)
- Privia Health Q1 2026 slides show operational strength, earnings disappoint (2026-05-07)
- Privia Health Group, Inc. (2021-04-28)
- gurufocus.com (2026-07-22)
- Privia acquires Evolent's value-based primary care unit for $100M (2025-09-24)
- Company Overview (2000-01-01)
- Navina and Privia Health Join Forces to Empower Physicians with Transformative AI Technology (2023-09-14)
- Privia Health Group Number of Employees 2026 (2026-06-29)
- Privia Medical Group Reports Data Breach Affects 2k (2025-11-17)
- What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors? (2026-07-12)